.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Serum Midkine HCC biomarker is transforming the management of liver malignancies, particularly in cases where traditional markers fall short. While alpha-fetoprotein (AFP) remains the standard, it often lacks the sensitivity required for early detection or monitoring AFP-negative patients. Recent clinical studies demonstrate that Midkine offers a more reliable alternative for assessing disease progression and treatment response. Consequently, this biomarker effectively differentiates between benign liver diseases and malignant hepatocellular carcinoma (HCC).
Research indicates that Midkine levels correlate strongly with critical clinicopathological features, including tumor size and Barcelona Clinic Liver Cancer (BCLC) stages. Therefore, higher serum concentrations often signal advanced clinical stages and poor prognosis. Furthermore, clinicians find this marker helpful in characterizing patients who do not show elevated AFP levels. Notably, Midkine’s efficacy in evaluating treatment efficacy is comparable to advanced imaging techniques like CT and MRI. This correlation is particularly beneficial for monitoring patients undergoing non-surgical therapies.
Moreover, multivariate regression models identify Midkine as a key predictive factor for hepatocellular carcinoma. By tracking these levels, healthcare providers can better evaluate the likelihood of disease recurrence or metastasis. Additionally, Midkine levels significantly decrease following successful tumor resection, making it an excellent tool for post-operative surveillance. Therefore, integrating Midkine into routine oncology protocols could lead to more personalized and effective treatment strategies for liver cancer patients.
Midkine exhibits high sensitivity even in patients with normal AFP levels, allowing for the detection and monitoring of HCC cases that might otherwise be missed.
Serum Midkine levels tend to decrease after successful intervention and rise during disease progression, providing a biochemical indicator of treatment efficacy similar to imaging scans.
Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Luo Y et al. Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication. J Clin Lab Anal. 2026 May 25. doi: 10.1002/jcla.70255. PMID: 42184120.
2. Lu Q, et al. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis. Biosci Rep. 2020;40(3):BSR20192424.
3. Zheng et al. Midkine (MDK) in Hepatocellular Carcinoma: More than a Biomarker. MDPI. 2024;16(2):112.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Serum Midkine emerges as a superior biomarker for HCC, specifically in AFP-negative patients, offering high sensitivity for monitoring treatment response....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
